Liposome induction of CD8+ T cell responses depends on CD169+ macrophages and Batf3-dependent dendritic cells and is enhanced by GM3 inclusion-Reference-Cited by-同舟云学术

Liposome induction of CD8+ T cell responses depends on CD169+ macrophages and Batf3-dependent dendritic cells and is enhanced by GM3 inclusion

Published:2021-03 Issue: Volume:331 Page:309-320
ISSN:0168-3659
Container-title:Journal of Controlled Release
language:en
Short-container-title:Journal of Controlled Release

Author:

Grabowska J.,Affandi A.J.,van Dinther D.,Nijen Twilhaar M.K.,Olesek K.,Hoogterp L.,Ambrosini M.,Heijnen D.A.M.,Klaase L.,Hidalgo A.,Asano K.,Crocker P.R.,Storm G.,van Kooyk Y.,den Haan J.M.M.

Funder

Nederlandse Organisatie voor Wetenschappelijk Onderzoek

Phospholipid Research Center

KWF Kankerbestrijding

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference76 articles.

1. Defining and understanding adaptive resistance in Cancer immunotherapy;Kim;Trends Immunol.,2018

2. Vaccines for established cancer: overcoming the challenges posed by immune evasion;van der Burg;Nat. Rev. Cancer,2016

3. Combination immunotherapy: a road map;Ott;J. Immunother. Cancer,2017

4. Combining vaccines and immune checkpoint inhibitors to prime, expand, and facilitate effective tumor immunotherapy;Collins;Expert Rev. Vaccines,2018

5. Therapeutic vaccination immunomodulation: forming the basis of all cancer immunotherapy;Coventry;Ther. Adv. Vaccin. Immunother.,2019

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bioactive sphingolipids as emerging targets for signal transduction in cancer development;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2024-09

2. Nanobody-liposomes as novel cancer vaccine platform to efficiently stimulate T cell immunity;International Journal of Pharmaceutics;2024-07

3. Potent cancer therapy by liposome microstructure tailoring with active-to-passive targeting and shell-to-core thermosensitive features;Materials Today Bio;2024-06

4. The predominant Quillaja Saponaria fraction, QS-18, is safe and effective when formulated in a liposomal murine cancer peptide vaccine;Journal of Controlled Release;2024-05

5. Vaccination with DC-SIGN-Targeting αGC Liposomes Leads to Tumor Control, Irrespective of Suboptimally Activated T-Cells;Pharmaceutics;2024-04-24